| Report ID | 278883 |
| Drug Identification Number | 00437999 |
| Brand name | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP |
| Common or Proper name | test |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE DEXTROSE POTASSIUM CHLORIDE |
| Strength(s) | 450MG 5G 150MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 11/22 |
| Anatomical Therapeutical Chemical (ATC) code | B05BB |
| Anatomical Therapeutical Chemical (ATC) description | I.V. SOLUTIONS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2027-01-02 |
| Actual start date | |
| Estimated end date | 2027-02-04 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-25 | French | Compare |
| v1 | 2026-02-25 | English | Compare |
Showing 1 to 2 of 2